PATENT CLAIM ANALYSIS

Application Number: 15752527
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-08
Patent Classification: ["435", "061000"]

Abstract:
The disclosure relates to the identification of a novel molecular signature based on the differential expression of circulating microRNAs (miRNA) in serum samples specific to patients with clinically significant diseases or disorders, such as cancer.

Claim (Index 9):
The method of any one of  claims 1 - 7  wherein the sample is a liquid biopsy obtained from an individual suffering from a disease.

Metadata:
- Claim Count in Document: 25.0
- Percentile: 88.0
- Lexical Diversity: 1.08333
- Patent Class: 435.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14686593', '12609847', '12963468', '14863828', '13390028']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6443364144884034
- 35 USC 102 Novelty (BERT): 0.5141595917554789
- Combined Prediction Score: 0.6313187322151109
- Mean Citation Score: 290.6146960000001
- Max Citation Score: 317.4949299999999
- Similarity Product: 256.03111007022136

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test